10.3 Solitary Thyroid Nodule & Thyroid Carcinoma

Solitary Thyroid Nodule & Thyroid Carcinoma

Diseases of the thyroid gland represent a classic high-yield domain in UPSC CMS surgery examinations. Management demands a clear step-by-step diagnostic pathway starting from symptom evaluation to fine-needle aspiration, followed by appropriate surgical resection and postoperative oncological surveillance.

---

1. Approach to a Solitary Thyroid Nodule (STN)

A Solitary Thyroid Nodule is defined as a clinically palpable discrete swelling in an otherwise normal thyroid gland. Although >85% of STNs are benign (colloid nodule, adenoma, simple cyst), ruling out thyroid carcinoma is mandatory.

Clinical Red Flags Suggestive of Malignancy

• Male gender or age extremes (<20 years or >60 years).
• History of childhood external neck irradiation (e.g. for thymic enlargement or lymphoma).
• Rapid expansion, hard/stony texture, or fixation to pre-thyroid muscles/trachea.
• Presence of ipsilateral cervical lymphadenopathy (Delphian or jugulodigastric nodes).
• Persistent hoarseness of voice (recurrent laryngeal nerve involvement), dyspnea, or dysphagia.

Stepwise Diagnostic Protocol

1. Serum TSH Level:
   • Low TSH (Suppressed): Indicates hyperfunctioning nodule. Perform Radionuclide Thyroid Scan (using I-123 or Tc-99m Pertechnetate).
     • Hot Nodule (increased uptake): Almost universally benign (<1% risk of malignancy). Treat hyperthyroidism.
     • Cold Nodule (decreased uptake): 15-20% risk of malignancy; proceed to USG and FNAC.
   • Normal or High TSH: Proceed directly to High-Resolution Neck Ultrasound.
2. High-Resolution Ultrasonography (USG): Suspicious ultrasound signs include microcalcifications, marked hypoechoicity, irregular/microlobulated margins, taller-than-wide shape (in sagittal view), and extrathyroidal extension (incorporated into TI-RADS risk stratification).
3. Fine Needle Aspiration Cytology (FNAC): Investigation of Choice for evaluating thyroid nodules.

---

2. Bethesda System for Reporting Thyroid Cytopathology

---

3. Histopathological Types of Thyroid Carcinoma

1. Papillary Thyroid Carcinoma (PTC)

• Frequency: Most common thyroid cancer (80-85%).
• Risk Factors: Head and neck ionizing radiation exposure in childhood.
• Pathognomonic Microscopic Features:
  1. Orphan Annie Eye Nuclei: Large, pale, empty-appearing optically clear nuclei with central chromatin clearing.
  2. Psammoma Bodies: Concentrically laminated calcified structures within tumor papillae.
  3. Nuclear Grooves and Intranuclear Cytoplasmic Pseudoinclusions.
• Mode of Spread: Predominantly via lymphatics to regional cervical lymph nodes (Level VI central compartment and Levels II-V lateral compartments). Hematogenous distant spread is rare (<5%).
• Prognosis: Excellent (>95% 10-year survival).

2. Follicular Thyroid Carcinoma (FTC)

• Frequency: Second most common (10-15%). Common in endemic iodine-deficient areas.
• Diagnostic Pitfall: FNAC CANNOT differentiate Follicular Adenoma from Follicular Carcinoma because the diagnosis relies entirely on demonstrating capsular invasion or vascular invasion on histopathology. Thus, FNAC reports this as Bethesda IV (Follicular Neoplasm), necessitating lobectomy for diagnosis.
• Mode of Spread: Predominantly hematogenous to bones (osteolytic, highly vascular metastases) and lungs. Lymphatic spread is rare (<5%).

3. Medullary Thyroid Carcinoma (MTC)

• Origin: Arises from neuroendocrine Parafollicular C-cells derived from the neural crest (ultimobranchial body), which secrete Calcitonin.
• Tumor Markers: Serum Calcitonin (used for diagnosis, post-op recurrence monitoring) and CEA.
• Histology: Sheets of polygonal cells separated by amyloid stroma that stains positive with Congo Red (shows apple-green birefringence under polarized light).
• Genetics: ~25% are familial, associated with MEN 2A or MEN 2B syndromes caused by germline mutations in the RET proto-oncogene. Mandatory screening of first-degree relatives for RET mutation (prophylactic total thyroidectomy indicated in carriers).

4. Anaplastic Thyroid Carcinoma

• Frequency: Rare (<2%), seen in elderly patients (>65 years).
• Clinical Presentation: Rapidly enlarging, stony-hard, fixed thyroid mass causing severe local compressive symptoms (stridor, dysphagia, superior vena cava syndrome).
• Microscopy: Highly pleomorphic, spindle cells, giant multinucleated cells with high mitotic index.
• Prognosis: Dismal; median survival <6 months. Treatment is largely palliative (tracheostomy, palliative radiotherapy).

---

4. Surgical Operations & Oncological Management

• Lobectomy / Hemithyroidectomy: Removal of one lobe along with the isthmus. Indicated for benign nodules, low-risk micro-PTC (<1 cm unifocal), or diagnostic evaluation of Bethesda IV lesions.
• Total Thyroidectomy: Complete removal of all thyroid tissue. Indicated for PTC/FTC >4 cm, bilateral tumors, extrathyroidal extension, or MTC.
• Central Neck Dissection (Level VI): Excision of pretracheal, paratracheal, and precricoid (Delphian) lymph nodes.
• Postoperative Radioiodine (RAI - I-131) Ablation: Administered 4-6 weeks after total thyroidectomy to eliminate microscopic residual thyroid tissue and treat distant metastases. Requires TSH elevation (>30 mIU/L achieved by levothyroxine withdrawal or recombinant human TSH).
• Levothyroxine Suppression: Post-op T4 therapy to suppress TSH below 0.1 mIU/L in high-risk patients, preventing TSH-driven tumor recurrence.

---

5. Post-Thyroidectomy Complications & Emergencies

1. Tension Hematoma (Reactionary Hemorrhage):
   • Mechanism: Venous or arterial bleeding under the deep cervical fascia causing tracheal compression.
   • Clinical Sign: Rapid neck swelling, respiratory distress, stridor, and cyanosis within 6 hours of surgery.
   • Immediate Action: Emergency bedside release of skin sutures and clips to evacuate the clot and relieve airway obstruction BEFORE transfer to the OR!
2. Recurrent Laryngeal Nerve (RLN) Injury:
   • Unilateral RLN Palsy: Vocal cord assumes a paramedian position; presents with hoarseness of voice and weak cough.
   • Bilateral RLN Palsy: Both vocal cords assume paramedian/median positions; presents with severe airway obstruction and stridor, requiring immediate emergency endotracheal intubation or tracheostomy.
3. External Branch of Superior Laryngeal Nerve (EBSLN) Injury:
   • Innervates the cricothyroid muscle (tenses vocal cords). Transection during upper pole ligation leads to loss of high-pitched voice and voice fatigue (Gall-Curci nerve).
4. Postoperative Hypocalcemia / Tetany:
   • Caused by inadvertent removal or ischemic necrosis of parathyroid glands.
   • Signs: Circumoral numbness, tingling of fingertips, Chvostek's sign (twitching of facial muscles on tapping facial nerve), and Trousseau's sign (carpopedal spasm induced by inflating BP cuff above systolic pressure for 3 mins).
   • Treatment: Acute tetany managed with IV Calcium Gluconate (10 ml of 10% solution) over 10 minutes.